MME and metabolic dysfunction-associated steatotic liver disease: Furthermore, in patients with obesity, diabetes, and MASLD, a high NEP expression has been found in the liver along with an enhanced NEP activity in the blood, with hepatic fat accumulation being a driver of increased circulating NEP [30].